FDA Revises Recommendations for Rotavirus Vaccine
May 15, 2010
The US Food and Drug Administration today revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and determined that it is appropriate for clinicians and health care professionals to resume the use of Rotarix and to continue the use of RotaTeq.
More information.
FDA Revises Recommendations for Rotavirus Vaccine has been found in News
To view this topic, please login.
Pediatric Care Online allows you to quickly access multiple pediatric resources, all in one place, for the most recent clinical information you need at the point-of-care.
View these topics FREE!

Quick Reference
Textbook
Bright Futures
For full access, please learn more.